Kuopio

Bavarian Nordic has appointed Tarja Stenvall as President and Chief Executive Officer, effective 15 October. She succeeds Paul Chaplin, whose departure was announced earlier this year.

The Life Science Cluster turns ten. But instead of looking in the rearview mirror, let’s look at why life science will matter more over the next decade.

More than 40% of women in the US say their health has limited their career, and the share rises to 66% among women who cannot get the care they need, according to a new Gallup survey conducted in partnership with Pivotal.

The European Medicines Agency’s human medicines committee (CHMP) has adopted a positive opinion recommending marketing authorisation for Novo Nordisk’s Frehemgo (denecimig) for haemophilia A, with or without inhibitors, in adults and children. The company says it is the first factor VIIIa mimetic offering once-monthly, once-every-two-weeks and once-weekly prophylaxis in a single-use pre-filled pen.